[EN] ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF<br/>[FR] ANALOGUES DE LA CYSTÉAMINE RÉSISTANT À L'ADO ET UTILISATIONS DE CEUX-CI
申请人:RAPTOR PHARMACEUTICALS INC
公开号:WO2017004485A1
公开(公告)日:2017-01-05
The present invention is directed to ADO-resistant cysteamine analogs for use in methods of treating diseases for which cysteamine is indicated, in particular cystinosis, fatty liver disease, fibrosis, thrombotic diseases, MECP-2 related disorders, inherited mitochondrial diseases, neurological diseases or disorders, inflammation and cancer.